OnKure Therapeutics, Inc.
NASDAQ:OKUR · NASDAQ Global Market
+$0.01 today
Vol 1.18M · Avg 0.37M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+85.89%
Period High
$5.27
Period Low
$2.00
Latest
$4.48
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Mersana Therapeutics, Inc.
MRSN
$145.36M
Xilio Therapeutics, Inc.
NASDAQ:XLO
$60.87M
Kezar Life Sciences, Inc.
KZR
$53.86M
PDS Biotechnology Corporation
NASDAQ:PDSB
$51.19M
FibroGen, Inc.
FGEN
$36.69M
Aligos Therapeutics, Inc.
ALGS
$32.83M
Actinium Pharmaceuticals, Inc.
ATNM
$32.00M
Barinthus Biotherapeutics plc
BRNS
$28.13M
CEL-SCI Corporation
CVM
$7.08M
Tempest Therapeutics, Inc.
TPST
$5.48M
What is the latest OKUR filing?
The latest filing shown is 4 dated Jun 8, 2026.
How many recent filings does OKUR have?
Intrinsic Alpha currently shows 20 recent filings for OKUR.
Explore More
Continue the stock analysis
Jump to another research area for this company.